Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Thorax|April 30, 2021
Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere lengthClaire F McGroder, David Zhang, Mohammad A Choudhury, et al.
The European Respiratory Journal|August 3, 2019
Circulating adhesion molecules and subclinical interstitial lung disease: the Multi-Ethnic Study of AtherosclerosisClaire F McGroder, Carrie P Aaron, Suzette J Bielinski, et al.
Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
Imaging, Pulmonary Function, and Histopathologic Findings of Persistent Fibrosis in a Longitudinal Cohort Three Years after Severe COVID-19 InfectionScarlett O Murphy, Claire F McGroder, Mary M Salvatore, et al.
Annals of the American Thoracic Society|July 1, 2025
Imaging, Pulmonary Function, and Histopathologic Findings of Persistent Fibrosis in a Longitudinal Cohort 3-Years after COVID-19Scarlett O Murphy, Claire F McGroder, Mary M Salvatore, et al.
Journal of Intensive Care Medicine|May 27, 2026
Subclinical Hypercoagulable Viscoelastic Characteristics Associated with Post-Acute Sequelae of SARS-CoV2 Physical Symptoms in COVID-19 ALI/ARDS SurvivorsAnsley E Jones, Margarita Mira-Sanchez, Zain Khan, et al.
Respiratory Research|November 29, 2025
Antiphospholipid antibodies and subclinical interstitial lung disease in the MESA cohortClaire F McGroder, Mary M Salvatore, John Newell, et al.
Respiratory Medicine|January 24, 2025
Antinuclear antibodies and progression of quantitative interstitial lung changes: The Multi-Ethnic Study of Atherosclerosis (MESA)-Lung StudyKathryn Friedman Flack, Michael D George, John S Kim, et al.
Critical Care Medicine|June 9, 2023
Fibrotic-Like Pulmonary Radiographic Patterns Are Not Associated With Adverse Outcomes in COVID-19 Chronic Critical IllnessPurnema Madahar, Kathleen M Capaccione, Mary M Salvatore, et al.
Pageof 2